MARCH1
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
162199copy number gainGRCh38/hg38 4q32.3(chr4:164306430-164542784)x3-1-4165227582165463936nana
162199copy number gainGRCh38/hg38 4q32.3(chr4:164306430-164542784)x3-1-4164306430164542784nana
162199copy number gainGRCh38/hg38 4q32.3(chr4:164306430-164542784)x3-1-4165447032165683386nana
243957copy number gainNC_000004.11:g.(?_164465746)_(164905719_?)dup-1-4164465746164905719nana
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
4164532973rs3792614CArs37926149.23E-04PROPYLTHIOURACILRECEPTORS, G-PROTEIN-COUPLED|TASTE RECEPTORS, TYPE 2Taste perceptionHPOID:0000223DOID:0050155GintronGWASdb_drug
4164922631rs11736201CTrs117362017.37E-04ALDOSTERONEBIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENINBlood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_drug
4164922836rs11736266CTrs117362668.57E-04ALDOSTERONEBIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENINBlood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_drug
4165201409rs17044858GArs170448581.76E-08CHOLESTEROLCADHERINS|H-CADHERIN|ADIPONECTIN|DNA PRIMERSAdiponectin levelsHPOID:0011014DOID:14221|DOID:9970|DOID:9352|DOID:1287GintronGWASdb_drug
4164446514rs17576350GArs175763504.09E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324GUTR-3GWASdb_trait
4164451948rs1992441CTrs19924412.51E-04Myocardial InfarctionHPOID:0001658DOID:5844AintronGWASdb_trait
4164459307rs3797023TCrs37970231.25E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324AintronGWASdb_trait
4164463778rs17473108AGrs174731089.49E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324AintronGWASdb_trait
4164466824rs13130399CTrs131303994.26E-04Glaucoma (primary open-angle)HPOID:0012108DOID:1686Ccds-synonGWASdb_trait
4164474770rs9631750TCrs96317507.89E-06Left ventricular hypertrophyHPOID:0001712DOID:11984TintronGWASdb_trait
4164522410rs1355504CGrs13555042.20E-05Urinary metabolitesHPOID:0000079DOID:557GintronGWASdb_trait
4164524609rs1912822CTrs19128221.44E-05Follicular lymphomaHPOID:0002665DOID:0060060GintronGWASdb_trait
4164532801rs3792615TCrs37926159.00E-06Type 2 diabetesHPOID:0005978DOID:9352AintronGWASdb_trait
4164560851rs13123027CTrs131230271.69E-04Glaucoma (primary open-angle)HPOID:0012108DOID:1686TintronGWASdb_trait
4164571285rs17473710GArs174737102.71E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312GintronGWASdb_trait
4164575991rs1533151ACrs15331511.51E-04Smoking initiationHPOID:0000707DOID:0050742TintronGWASdb_trait
4164582457rs1511776GArs15117763.02E-04Body mass indexHPOID:0001507DOID:9970CintronGWASdb_trait
4164589328rs13114557GCrs131145574.67E-04Smoking initiationHPOID:0000707DOID:0050742CintronGWASdb_trait
4164617856rs1039959GCrs10399592.94E-04Suicide, with and without major depressionHPOID:0000716DOID:1470G,CintronGWASdb_trait
4164623358rs1170300GCrs11703002.67E-04Acute lung injuryHPOID:0002088DOID:850CintronGWASdb_trait
4164634372rs1565840CArs15658409.18E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324TintronGWASdb_trait
4164637972rs6818812CTrs68188127.49E-05Monocyte countsHPOID:0012310DOID:1936|DOID:74TintronGWASdb_trait
4164646996rs6536751CTrs65367516.00E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312TintronGWASdb_trait
4164666859rs17577474GArs175774743.52E-04Type 2 diabetesHPOID:0005978DOID:9352GintronGWASdb_trait
4164669428rs12504820CTrs125048202.15E-05Monocyte countsHPOID:0012310DOID:1936|DOID:74CintronGWASdb_trait
4164701659rs1038975GArs10389756.90E-05Monocyte countsHPOID:0012310DOID:1936|DOID:74CintronGWASdb_trait
4164748523rs2131862GArs21318621.42E-05Monocyte countsHPOID:0012310DOID:1936|DOID:74CintronGWASdb_trait
4164753387rs1874094CTrs18740949.25E-05Response to mTOR inhibitor (everolimus)HPOID:0002665|HPOID:0005584|HPOID:0003002|HPOID:0100526|HPOID:0012114|HPOID:0100843DOID:4450|DOID:1612|DOID:3908|DOID:2871|DOID:3068|DOID:0050746GintronGWASdb_trait
4164758471rs11939053ACrs119390538.91E-04Alzheimer's diseaseHPOID:0002511DOID:10652AintronGWASdb_trait
4164758471rs11939053ACrs119390533.14E-05Monocyte countsHPOID:0012310DOID:1936|DOID:74AintronGWASdb_trait
4164758578rs7680927AGrs76809275.18E-04Alzheimer's diseaseHPOID:0002511DOID:10652AintronGWASdb_trait
4164758636rs7681115AGrs76811155.96E-04Alzheimer's diseaseHPOID:0002511DOID:10652AintronGWASdb_trait
4164780120rs978402TCrs9784024.10E-04Type 2 diabetes and 6 quantitative traitsHPOID:0005978DOID:9352AintronGWASdb_trait
4164782515rs7655259CArs76552594.41E-05Amyotrophic lateral sclerosis (sporadic)HPOID:0007354DOID:332AintronGWASdb_trait
4164796501rs12645283TCrs126452839.27E-05Cytomegalovirus antibody responseHPOID:0004377DOID:10533TintronGWASdb_trait
4164798037rs4554022GTrs45540228.35E-05Cytomegalovirus antibody responseHPOID:0004377DOID:10533GintronGWASdb_trait
4164809025rs10023694GTrs100236946.06E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324GintronGWASdb_trait
4164829751rs3890761TCrs38907616.12E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324TintronGWASdb_trait
4164915259rs12510039GArs125100399.63E-05Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
4164916190rs4453901ACrs44539018.04E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
4164922631rs11736201CTrs117362017.37E-04Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_trait
4164922836rs11736266CTrs117362668.57E-04Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_trait
4164934874rs10007601GArs100076011.60E-04Body mass indexHPOID:0001507DOID:9970AintronGWASdb_trait
4164941538rs17044409AGrs170444091.52E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
4164958626rs10001082TCrs100010823.00E-06Parkinson's disease (interaction with coffee consumption)HPOID:0001300DOID:14330CintronGWASdb_trait
4164959804rs4533720AGrs45337204.00E-07Urinary uromodulin levelsHPOID:0000077DOID:557GintronGWASdb_trait
4164972162rs6536779TCrs65367797.21E-05Tunica MediaHPOID:0001627DOID:114TintronGWASdb_trait
4164980534rs13130053CTrs131300531.90E-05Urinary metabolitesHPOID:0000079DOID:557CintronGWASdb_trait
4164981604rs17613361AGrs176133612.41E-04HeightHPOID:0000002NAAintronGWASdb_trait
4165007900rs41513048GArs415130482.35E-04Multiple complex diseasesHPOID:0000118NACintronGWASdb_trait
4165013565rs919574GArs9195742.64E-05Telomere lengthHPOID:0000118NAAintronGWASdb_trait
4165014174rs7659197GTrs76591975.14E-04Multiple complex diseasesHPOID:0000118NATintronGWASdb_trait
4165029168rs17044483ATrs170444832.30E-05Urinary metabolitesHPOID:0000079DOID:557AintronGWASdb_trait
4165043263rs2952334AGrs29523341.30E-05Urinary metabolitesHPOID:0000079DOID:557AintronGWASdb_trait
4165054490rs919572ATrs9195723.58E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
4165060898rs982257TCrs9822571.31E-04Body mass indexHPOID:0001507DOID:9970CintronGWASdb_trait
4165077427rs6840738ACrs68407383.38E-04Multiple complex diseasesHPOID:0000118NACintronGWASdb_trait
4165085789rs1431001ATrs14310012.39E-04Glycosylated haemoglobin levelsHPOID:0011902|HPOID:0000077|HPOID:0001626|HPOID:0000819|HPOID:0000479DOID:1287|DOID:9351|DOID:557|DOID:5679TintronGWASdb_trait
4165085902rs1430999GArs14309993.13E-05Glucose levelsHPOID:0000819DOID:9352CintronGWASdb_trait
4165093156rs17044711CTrs170447111.73E-05Glucose levelsHPOID:0000819DOID:9352CintronGWASdb_trait
4165095228rs1160724CTrs11607242.40E-04Body mass indexHPOID:0001507DOID:9970AintronGWASdb_trait
4165099463rs1430979TA,Grs14309792.04E-04Body mass indexHPOID:0001507DOID:9970CintronGWASdb_trait
4165106489rs1549807GArs15498072.24E-04Body mass indexHPOID:0001507DOID:9970TintronGWASdb_trait
4165108780rs1430977GArs14309772.07E-05Glucose levelsHPOID:0000819DOID:9352TintronGWASdb_trait
4165132967rs10001526GTrs100015261.20E-05Urinary metabolitesHPOID:0000079DOID:557GintronGWASdb_trait
4165147509rs17614208GArs176142087.98E-06HeightHPOID:0000002NAGintronGWASdb_trait
4165160898rs3890821ACrs38908211.66E-05Glycosylated haemoglobin levelsHPOID:0011902|HPOID:0000077|HPOID:0001626|HPOID:0000819|HPOID:0000479DOID:1287|DOID:9351|DOID:557|DOID:5679TintronGWASdb_trait
4165201409rs17044858GArs170448581.76E-08Adiponectin levelsHPOID:0011014DOID:14221|DOID:9970|DOID:9352|DOID:1287GintronGWASdb_trait
4165202782rs2321376GArs23213761.75E-04Coronary Artery DiseaseHPOID:0001677DOID:3393CintronGWASdb_trait
4165216639rs4611881GCrs46118817.85E-04Coronary Artery DiseaseHPOID:0001677DOID:3393GintronGWASdb_trait
4165221971rs6829588GTrs68295888.31E-04Obesity (extreme)HPOID:0001513DOID:9970TintronGWASdb_trait
4165268349rs13125269AGrs131252693.23E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
4165278592rs12506846CTrs125068466.02E-04Multiple complex diseasesHPOID:0000118NACintronGWASdb_trait
4165284574rs4431170AGrs44311700.00000728Bisphosphonate-induced osteonecrosis of the jawHPOID:0003368DOID:10159AintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000145416.13 MARCH1 613331